Navigation Links
Breast cancer multigene test helping patients avoid chemotherapy
Date:1/11/2010

MAYWOOD, Il. -- A 21-gene test that predicts whether early stage breast cancer patients will benefit from chemotherapy is having a big impact on treatment decisions by patients and doctors alike.

The test caused doctors to change their treatment recommendations in 31.5 percent of cases, while 27 percent of patients changed their treatment decisions. In most such cases, the change by both doctors and patients was to avoid chemotherapy.

The study, lead by Loyola University Health System Medical oncologist Dr. Shelly Lo, is published in the Journal of Clinical Oncology.

The multigene test, Oncotype DX, is made by Genomic Health Inc. The test examines 21 genes from a tumor sample to determine how active they are. A test score between 0 and 100 predicts how likely the cancer is to recur. For women with low scores, chemotherapy is not recommended.

More than 120,000 breast cancer patients have undergone the test since it became commercially available in 2004. The test is intended for patients who have a type of breast cancer, called estrogen receptor-positive that has not spread to the lymph nodes. About 100,000 such cases are diagnosed each year.

"The trend in oncology is towards personalized medicine," Lo said. "We likely will see more tests similar to this one in the future."

The study included 89 breast cancer patients who received the gene test. They were treated by 17 medical oncologists at Loyola, University of Michigan, University of California at Davis and Edward Hospital in Naperville, Il.

Doctors changed treatment decisions for 28 patients. In 20 of these cases, they changed their decision from hormone therapy plus chemotherapy to hormone therapy alone. Twenty-four patients changed their treatment decisions, including nine who dropped chemotherapy.

"This is the first study to show that results from this test simultaneously impact decisions by physicians as well as patients," Lo
'/>"/>

Contact: Jim Ritter
jritter@lumc.edu
708-216-2445
Loyola University Health System
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Survival differences by race most apparent in advanced stages of breast cancer
2. MRI finds breast cancer before it becomes dangerous
3. Pathway links inflammation, angiogenesis and breast cancer
4. Drop in breast cancer incidence linked to hormone use, not mammograms
5. Breast cancer prevention practices vary across Canada
6. Eating junk food whilst pregnant and breastfeeding may lead to obese offspring
7. Acrylamide Wont Raise Breast Cancer Risk
8. New link between estrogen and breast cancer
9. Hypnosis Eases Pain of Breast Cancer Surgery
10. Discovery suggests location of genes for breast density, a strong risk factor for breast cancer
11. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... 18, 2013 The Communities of Distinction ... places we call home. These are the townships, villages and ... the locations where the people are friendly and neighbors are ... off the highways and shares the best in both the ... with an American sports and film celebrity. It airs in ...
(Date:5/18/2013)... 18, 2013 The “World Healthcare IT ... studies the major market drivers, restraints, and opportunities in ... , Browse , 89 market ... TOC on "Healthcare IT Market" , ... on reports. , The global healthcare IT market is ...
(Date:5/18/2013)... 2013 TheBeautyPlace.com answers important questions about ... is not a result of stress, nutrient deficiency or ... Magazine, 70% of men suffer from male patterned baldness. ... renowned for hair transplant surgery, but additionally carries a ... known as Bosley Professional Strength. Their product line is ...
(Date:5/18/2013)... May 18, 2013 As metal-on-metal ... throughout the country, Bernstein Liebhard LLP notes that a ... often suffer tissue damage before they experience any pain ... to Science Daily will appear in the Journal of ... underwent MRI screens of their hips. The researchers ...
(Date:5/18/2013)... Although obesity is associated with an increased risk ... esophageal adenocarcinoma, a type of esophageal cancer, is stronger ... on Cancer.gov, last reviewed in January 2012, overweight ... those of normal and healthy weight to develop this ... cancer is not well understood, it is now thought ...
Breaking Medicine News(10 mins):Health News:Communities of Distinction TV Presents "A Place to Call Home" Segment 2Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 2Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 3Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 2Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 3Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 2Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 3Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 4Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 3
... can reduce blood pressure without causing weight gain or other ... the United States. ,Previous research has shown that ... that any benefit could be offset by high doses of ... German researchers at the University of Cologne sought to examine ...
... US tuberculosis patient under mandatory isolation since his Greek ... serious strain of the disease than initially thought, ... travels, including seven flights and an overland trip from ... when the US Centers for Disease Control (CDC) said ...
... in assisted reproduction may diminish the effectiveness of medical ... a scientist in 23rd annual conference of the European ... ,Dr. Jacky Boivin, from the School of ... research had also shown that women who used complementary ...
... of a rash in cancer patients treated with erlotinib ... is not the first time that rash has been associated ... of drugs which includes erlotinib, cetuximab, panitumumab and others designed ... but it is the most detailed analysis to date. ...
... Forget expensive moisturisers and cosmetic surgery, a compound found in ... ,In the first study of its kind, ... the University of East Anglia and Dr Paul Kroon at ... condition is improved by a compound which gives berries their ...
... A role for prion proteins, the much debated agents of ... appears that the normal prions produced by the body help ... to cause Alzheimers disease. ,The possible function for ... led by Medical Research Council funded scientist Professor Nigel Hooper ...
Cached Medicine News:Health News:Daily Dose of Dark Chocolate Helps the Heart: Study 2Health News:US Traveler With Deadly TB Has Less Serious Strain 2Health News:Complementary Therapy may Reduce Pregnancy Chances in Women 2Health News:Skin Rashes Signifies Longer Survival in Cancer Patients 2Health News:Skin Rashes Signifies Longer Survival in Cancer Patients 3Health News:Prions Prevent Alzheimers Disease 2
(Date:5/17/2013)... May 17, 2013  Orexigen® Therapeutics, Inc. (Nasdaq: ... overview at the UBS Global Healthcare Conference in ... May 22 nd at 11 a.m. Eastern Time. To ... presentation, please visit the Investor Relations section of the Company,s ... available for 14 days after the event. About ...
(Date:5/17/2013)... 17, 2013  Sony Biotechnology Inc. ("Sony") today announced the ... and 130um sorting chip.  Sony will also be exhibiting its ... SH800 Cell Sorter, the EC800 flow cytometer, and new SP6800 ... 2013, which will be held at the San ... California , from May 20 - 22.  ...
(Date:5/17/2013)... , May 17, 2013 ... health economics and outcomes research also   to   ... NASDAQ: SHPG ), the global specialty biopharmaceutical ... 7 poster presentations at the American Psychiatric Association (APA) ... , May 18-22. The data being presented represent Shire,s ...
Breaking Medicine Technology:Sony Delivers New Technology for Science to CYTO 2013 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 3Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 4Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 5Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 6Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 7Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 8Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 9Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 10
... TRIANGLE PARK, N.C., Feb. 15, 2011 Talecris Biotherapeutics Holdings ... has removed TLCR from the NASDAQ Biotechnology Index(R) (Nasdaq: NBI) ... The change takes effect Feb. 15 prior to the market,s ... to provide stockholders with advance notice of a company,s anticipated ...
... Cayenne Medical, Inc., a private sports medicine device company, ... soft tissue repair device for multi-ligament repairs of the ... American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting in ... II is the introduction of its new Cannulated Tibial ...
Cached Medicine Technology:Cayenne Medical, Inc. Launches AperFix® II 2
VersaStep™ Reposable Sterilization Trays....
Sterile Structural Balloon Trocar (SBT) with Pre-Formed Inelastic Balloon and Foam Collar Anchoring System....
... Step™ and Mini Step™ device components are supplied ... Single Use System is supplied sterile in 2/3, ... in various configurations and combinations. They are used ... needle and the Step™ radially Expandable Sleeve. The ...
... components are supplied sterile. , ,The Step™ ... sterile in 2/3, 5, 7/8, 10 and 12 ... They are used in conjunction with the Step™ ... Expandable Sleeve. The 5, 7/8, 10 and 12 ...
Medicine Products: